These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

434 related items for PubMed ID: 19920784

  • 1. Heart rate reduction for 12 months with ivabradine reduces left ventricular mass in cardiac allograft recipients.
    Doesch AO, Ammon K, Konstandin M, Celik S, Kristen A, Frankenstein L, Buss S, Hardt S, Sack FU, Katus HA, Dengler TJ.
    Transplantation; 2009 Sep 27; 88(6):835-41. PubMed ID: 19920784
    [Abstract] [Full Text] [Related]

  • 2. Heart rate reduction after heart transplantation with beta-blocker versus the selective If channel antagonist ivabradine.
    Doesch AO, Celik S, Ehlermann P, Frankenstein L, Zehelein J, Koch A, Katus HA, Dengler TJ.
    Transplantation; 2007 Oct 27; 84(8):988-96. PubMed ID: 17989604
    [Abstract] [Full Text] [Related]

  • 3. Heart rate reduction for 36 months with ivabradine reduces left ventricular mass in cardiac allograft recipients: a long-term follow-up study.
    Doesch AO, Mueller S, Erbel C, Gleissner CA, Frankenstein L, Hardt S, Ruhparwar A, Ehlermann P, Dengler T, Katus HA.
    Drug Des Devel Ther; 2013 Oct 27; 7():1323-8. PubMed ID: 24235815
    [Abstract] [Full Text] [Related]

  • 4. Control of cardiac chronotropic function in patients after heart transplantation: effects of ivabradine and metoprolol succinate on resting heart rate in the denervated heart.
    Rivinius R, Helmschrott M, Ruhparwar A, Rahm AK, Darche FF, Thomas D, Bruckner T, Ehlermann P, Katus HA, Doesch AO.
    Clin Res Cardiol; 2018 Feb 27; 107(2):138-147. PubMed ID: 29098378
    [Abstract] [Full Text] [Related]

  • 5. Impact of a pure reduction in heart rate for the treatment of left ventricular dysfunction: clinical benefits of ivabradine in the BEAUTIFUL trial.
    Danchin N.
    Therapie; 2009 Feb 27; 64(2):111-4. PubMed ID: 19664404
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of ivabradine in four patients with inappropriate sinus tachycardia: a three month-long experience based on electrocardiographic, Holter monitoring, exercise tolerance and quality of life assessments.
    Kaplinsky E, Comes FP, Urondo LS, Ayma FP.
    Cardiol J; 2010 Feb 27; 17(2):166-71. PubMed ID: 20544616
    [Abstract] [Full Text] [Related]

  • 7. Safety of ivabradine in patients with coronary artery disease and left ventricular systolic dysfunction (from the BEAUTIFUL Holter Substudy).
    Tendera M, Talajic M, Robertson M, Tardif JC, Ferrari R, Ford I, Steg PG, Fox K, BEAUTIFUL Investigators.
    Am J Cardiol; 2011 Mar 15; 107(6):805-11. PubMed ID: 21247517
    [Abstract] [Full Text] [Related]

  • 8. Ivabradine: in adults with chronic heart failure with reduced left ventricular ejection fraction.
    Perry CM.
    Am J Cardiovasc Drugs; 2012 Dec 01; 12(6):415-26. PubMed ID: 23181944
    [Abstract] [Full Text] [Related]

  • 9. Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study.
    Swedberg K, Komajda M, Böhm M, Borer J, Robertson M, Tavazzi L, Ford I, SHIFT Investigators.
    J Am Coll Cardiol; 2012 May 29; 59(22):1938-45. PubMed ID: 22617188
    [Abstract] [Full Text] [Related]

  • 10. Five-year results of heart rate control with ivabradine or metoprolol succinate in patients after heart transplantation.
    Rivinius R, Helmschrott M, Rahm AK, Darche FF, Thomas D, Bruckner T, Doesch AO, Katus HA, Ehlermann P.
    Clin Res Cardiol; 2022 Feb 29; 111(2):141-153. PubMed ID: 32572551
    [Abstract] [Full Text] [Related]

  • 11. Lasting reduction of heart transplant tachycardia with ivabradine is effective and well tolerated: results of 48-month study.
    Zhang R, Bobylev D, Stiefel P, Haverich A, Bara C.
    Clin Res Cardiol; 2012 Aug 29; 101(8):631-6. PubMed ID: 22391988
    [Abstract] [Full Text] [Related]

  • 12. Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice.
    Custodis F, Baumhäkel M, Schlimmer N, List F, Gensch C, Böhm M, Laufs U.
    Circulation; 2008 May 06; 117(18):2377-87. PubMed ID: 18443241
    [Abstract] [Full Text] [Related]

  • 13. Effect of long-term heart rate reduction by If current inhibition on pressure overload-induced heart failure in rats.
    Ciobotaru V, Heimburger M, Louedec L, Heymes C, Ventura-Clapier R, Bedossa P, Escoubet B, Michel JB, Mercadier JJ, Logeart D.
    J Pharmacol Exp Ther; 2008 Jan 06; 324(1):43-9. PubMed ID: 17901295
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of ivabradine in a case of inappropriate sinus tachycardia and ventricular dysfunction.
    Sette A, Martino A, Lioy E, Calò L.
    J Cardiovasc Electrophysiol; 2010 Jul 06; 21(7):815-7. PubMed ID: 20233274
    [Abstract] [Full Text] [Related]

  • 15. Effect of metoprolol and ivabradine on left ventricular remodelling and Ca2+ handling in the post-infarction rat heart.
    Maczewski M, Mackiewicz U.
    Cardiovasc Res; 2008 Jul 01; 79(1):42-51. PubMed ID: 18310678
    [Abstract] [Full Text] [Related]

  • 16. Effects of ivabradine on allograft function and exercise performance in heart transplant recipients with permanent sinus tachycardia.
    Zhang R, Haverich A, Strüber M, Simon A, Pichlmaier M, Bara C.
    Clin Res Cardiol; 2008 Nov 01; 97(11):811-9. PubMed ID: 18648727
    [Abstract] [Full Text] [Related]

  • 17. Ivabradine: beyond heart rate control.
    Riccioni G, Vitulano N, D'Orazio N.
    Adv Ther; 2009 Jan 01; 26(1):12-24. PubMed ID: 19165437
    [Abstract] [Full Text] [Related]

  • 18. Limited role for ivabradine in the treatment of chronic heart failure.
    Cullington D, Goode KM, Cleland JG, Clark AL.
    Heart; 2011 Dec 01; 97(23):1961-6. PubMed ID: 21917660
    [Abstract] [Full Text] [Related]

  • 19. Heart rate reduction with ivabradine improves energy metabolism and mechanical function of isolated ischaemic rabbit heart.
    Ceconi C, Cargnoni A, Francolini G, Parinello G, Ferrari R.
    Cardiovasc Res; 2009 Oct 01; 84(1):72-82. PubMed ID: 19477966
    [Abstract] [Full Text] [Related]

  • 20. I(f) current inhibitor ivabradine in patients with idiopathic dilated cardiomyopathy: Impact on the exercise tolerance and quality of life.
    Abdel-Salam Z, Rayan M, Saleh A, Abdel-Barr MG, Hussain M, Nammas W.
    Cardiol J; 2015 Oct 01; 22(2):227-32. PubMed ID: 25179314
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.